Inmaculada López-Hernández

707 total citations
27 papers, 350 citations indexed

About

Inmaculada López-Hernández is a scholar working on Molecular Medicine, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Inmaculada López-Hernández has authored 27 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 12 papers in Epidemiology and 9 papers in Clinical Biochemistry. Recurrent topics in Inmaculada López-Hernández's work include Antibiotic Resistance in Bacteria (16 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Inmaculada López-Hernández is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Inmaculada López-Hernández collaborates with scholars based in Spain, Netherlands and Italy. Inmaculada López-Hernández's co-authors include Álvaro Pascual, Lorena López‐Cerero, Mark W. Silby, Eduardo A. Robleto, Stuart B. Levy, Jesús Rodríguez‐Baño, Guillermo Blanco, Felipe Fernández-Cuenca, Francisco Morinha and Mercedes Delgado-Valverde and has published in prestigious journals such as The Science of The Total Environment, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Inmaculada López-Hernández

25 papers receiving 340 citations

Peers

Countries citing papers authored by Inmaculada López-Hernández

Since Specialization

Citations

This map shows the geographic impact of Inmaculada López-Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada López-Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada López-Hernández more than expected).

Fields of papers citing papers by Inmaculada López-Hernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada López-Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada López-Hernández. The network helps show where Inmaculada López-Hernández may publish in the future.

Co-authorship network of co-authors of Inmaculada López-Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada López-Hernández. A scholar is included among the top collaborators of Inmaculada López-Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada López-Hernández. Inmaculada López-Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study 2024 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Francesco Cogliati Dezza, Inmaculada López-Hernández, (unknown), (unknown), María Teresa Pérez-Rodríguez, Jonathan Fernández-Suárez, Eva María León Jiménez, Miguel Ángel Morán Rodríguez, (unknown), (unknown), (unknown), (unknown), Lucía Boix-Palop, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
2	Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC 2024 ·International Journal of Infectious Diseases ·(unknown), (unknown), Pérez Rodríguez, Adrián Sousa, Josune Goikoetxea, (unknown), Carlos Armiñanzas, Inmaculada López-Hernández, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño	1
3	Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions 2024 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), (unknown), (unknown), (unknown), Inmaculada López-Hernández, Marı́a Pérez-Vázquez, Belén Aracil, Lorena López‐Cerero, Pablo A. Fraile-Ribot, Antonio Oliver, Juan Carlos Vázquez-Ucha, Alejandro Beceiro, Germán Bou, Jorge Arca-Suárez	17
4	Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales 2024 ·Antimicrobial Agents and Chemotherapy ·(unknown), Inmaculada López-Hernández, Belén Aracil, (unknown), (unknown), (unknown), Salud Rodríguez-Pallares, (unknown), (unknown), Marı́a Pérez-Vázquez, Juan Carlos Vázquez-Ucha, Alejandro Beceiro, Álvaro Pascual, Germán Bou, Lorena López‐Cerero, Jesús Calatayud, Jorge Arca-Suárez, (unknown)	9
5	Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection 2023 ·Frontiers in Medicine ·Lucía Blasco, Inmaculada López-Hernández, (unknown), Javier Pérez-Florido, Carlos S. Casimiro‐Soriguer, Sarah Djebara, Maya Merabishvili, Jean‐Paul Pirnay, Jesús Rodríguez‐Baño, María Tomás, Luis Eduardo López-Cortés	34
6	The role of the microbiology laboratory in the diagnosis of multidrug-resistant Gram-negative bacilli infections. The importance of the determination of resistance mechanisms 2022 ·Medicina Intensiva (English Edition) ·Inmaculada López-Hernández, Lorena López‐Cerero, Felipe Fernández-Cuenca, Álvaro Pascual	3
7	Molecular characterisation of an outbreak of NDM-7-producing Klebsiella pneumoniae reveals ST11 clone expansion combined with interclonal plasmid dissemination 2022 ·International Journal of Antimicrobial Agents ·Jesús Machuca, Lorena López‐Cerero, (unknown), Felipe Fernández-Cuenca, Inmaculada López-Hernández, Mercedes Delgado-Valverde, (unknown), Álvaro Pascual	2
8	Infections in patients colonized with carbapenem-resistant Gram-negative bacteria in a medium Spanish city 2021 ·Revista Española de Quimioterapia ·(unknown), Mercedes Delgado-Valverde, (unknown), Inmaculada López-Hernández, José María Navarro‐Marí, José Gutiérrez Fernández, (unknown)	4
9	Carbapenemase-Producing Gram-Negative Bacteria in Andalusia, Spain, 2014–2018 2020 ·Emerging infectious diseases ·Inmaculada López-Hernández, Mercedes Delgado-Valverde, Felipe Fernández-Cuenca, Lorena López‐Cerero, Jesús Machuca, Álvaro Pascual	18
10	Intensive farming as a source of bacterial resistance to antimicrobial agents in sedentary and migratory vultures: Implications for local and transboundary spread 2020 ·The Science of The Total Environment ·Guillermo Blanco, Inmaculada López-Hernández, Francisco Morinha, Lorena López‐Cerero	26
11	Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade 2020 ·Clinical Microbiology and Infection ·(unknown), Luis Eduardo López-Cortés, Pilar Retamar, (unknown), David Vinuesa García, Eva León, (unknown), Fátima Galán‐Sánchez, (unknown), Alfonso del Arco, Antonio Sánchez-Porto, Carmen Rodríguez, (unknown), (unknown), (unknown), (unknown), (unknown), Inmaculada López-Hernández, Jesús Rodríguez‐Baño	13
12	Characterization of NDM-1- and CMH-3-producing Enterobacter cloacae complex ST932 in a patient transferred from Ukraine to Spain 2019 ·Enfermedades Infecciosas y Microbiología Clínica ·Inmaculada López-Hernández, (unknown), Paula Díaz de Alba, Encarnación Clavijo, Álvaro Pascual	11
13	First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain 2019 ·Enfermedades Infecciosas y Microbiología Clínica ·Felipe Fernández-Cuenca, Patricia Pérez‐Palacios, Fátima Galán‐Sánchez, Lorena López‐Cerero, Inmaculada López-Hernández, (unknown), Jorge Arca-Suárez, (unknown), (unknown), Álvaro Pascual	22
14	Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain 2017 ·Microbial Drug Resistance ·Inmaculada López-Hernández, Jesús Machuca, Paula Díaz de Alba, (unknown), Frederic Gómez‐Bertomeu, José Manuel Rodríguez-Martínez, Álvaro Pascual	5
15	Activity of ceftazidime•avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance 2017 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·Inmaculada López-Hernández, (unknown), Marta Fernández-Martínez, Laura Zamorano, Alba Rivera, Antonio Oliver, M. Carmen Conejo, Luis Martínez‐Martínez, Ferrán Navarro, Álvaro Pascual	1
16	Hepatitis aguda fulminante por virus B durante el tratamiento del virus de la hepatitis C con antivirales de acción directa en paciente infectado con VIH 2017 ·Enfermedades Infecciosas y Microbiología Clínica ·(unknown), Inmaculada López-Hernández, Felipe Fernández-Cuenca, Maria José Ríos-Villegas	1
17	Activity of ceftazidime–avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance 2016 ·Enfermedades Infecciosas y Microbiología Clínica ·Inmaculada López-Hernández, (unknown), Marta Fernández-Martínez, Laura Zamorano, Alba Rivera, Antonio Oliver, M. Carmen Conejo, Luis Martínez‐Martínez, Ferrán Navarro, Álvaro Pascual	10
18	Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial 2015 ·BMJ Open ·Clara Rosso-Fernández, Jesús Sojo-Dorado, Ángel Díaz Barriga, (unknown), (unknown), Inmaculada López-Hernández, (unknown), (unknown), Álvaro Pascual, Jesús Rodríguez‐Baño, (unknown)	52
19	First report of linezolid dependence in methicillin-resistant Staphylococcus aureus 2015 ·Clinical Microbiology and Infection ·Inmaculada López-Hernández, Mercedes Delgado-Valverde, (unknown), Álvaro Pascual	8
20	Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain 1997 ·Clinical Microbiology and Infection ·Luis Martínez‐Martínez, Inmaculada López-Hernández, Álvaro Pascual, Ana Isabel Suárez, Evelio J. Perea	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact